C. LaValle

发表

Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells

Liyong Zhang, F. Deng, Q. J. Wang, 2017, Oncotarget.

Protein kinase D as a potential new target for cancer therapy.

P. Wipf, J. Lazo, E. Sharlow, 2010, Biochimica et biophysica acta.

Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility

P. Wipf, J. Lazo, E. Sharlow, 2010, BMC chemical biology.

Potent and Selective Disruption of Protein Kinase D Functionality by a Benzoxoloazepinolone*

P. Wipf, J. Lazo, E. Sharlow, 2008, Journal of Biological Chemistry.

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma

G. Mills, J. Siegfried, A. Egloff, 2012, Clinical Cancer Research.

Prognosis Tumor Epidermal Growth Factor Receptor and EGFRPY 1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma

G. Mills, J. Siegfried, A. Egloff, 2012 .

TARGETING PROTEIN KINASE D BY NOVEL SMALL MOLECULE INHIBITORS AND RNA INTERFERENCE IN PROSTATE CANCER

Courtney R Lavalle, C. LaValle, 2011 .

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

P. Wipf, J. Lazo, E. Sharlow, 2011, Pharmaceutics.

Synthesis and Structure−Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D

P. Wipf, J. Lazo, E. Sharlow, 2011 .

Protein kinase D as a potential new target for cancer therapy.

E. Sharlow, Kara M. George, J. Lazo, 2010, Biochimica et biophysica acta.

Potent and Selective Disruption of Protein Kinase D Functionality by a Benzoxoloazepinolone*

P. Wipf, J. Lazo, E. Sharlow, 2008, Journal of Biological Chemistry.

Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma

Simion I. Chiosea, Lin Wang, J. Grandis, 2018, BMC Cancer.